One-two punch treatment delivers blood cancer knockout

A novel combination of two cancer drugs has shown great potential as a future treatment for patients with acute myeloid leukaemia (AML), one of the most common types of blood cancers. A new study has revealed the combination of two existing drugs eradicated AML cancer cells in lab-based tests. The discovery could soon lead to clinical trials.